Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Diagnostics (Basel, Switzerland)|March 6, 2021
Urinary Cell-Free DNA in Bladder Cancer DetectionRyan Tsz-Hei Tse, Hongda Zhao, Christine Yim-Ping Wong, et al.Cancers|August 10, 2024
Impact of Pre-Operative Ureteroscopy on Bladder Recurrence Following Nephroureterectomy for UTUCChris Ho-Ming Wong, Ivan Ching-Ho Ko, David Ka-Wai Leung, et al.Plos One|October 19, 2022
In vitro cytotoxicity of human urine and its potential toxic parameters towards bladder cancer cellsHongda Zhao, Ryan Tsz-Hei Tse, Carol Ka-Lo Cheng, et al.Journal of Cellular Biochemistry|September 20, 2018
CCL17-CCR4 axis promotes metastasis via ERK/MMP13 pathway in bladder cancerHongda Zhao, Qiyu Bo, Weifen Wang, et al.European Urology Oncology|May 28, 2026
EZH2 Inhibition Remodels Cell States and Enhances EGFRi Sensitization in Bladder CancerHongda Zhao, Jinyue Liao, Ho Vincy Wing Sze, et al.International Urology and Nephrology|June 30, 2025
A cross-sectional study on the effects of intravesical BCG on urinary microbiota in bladder cancer patientsJoseph Kai Man Li, Lin Wang, Ryan Tsz Hei Tse, et al.Bladder Cancer (Amsterdam, Netherlands)|April 29, 2025
Organoid models in bladder cancer: From bench to bedside?Hongda Zhao, Vincy Wing Sze Ho, Kang Liu, et al.Asian Journal of Urology|February 5, 2024
Defining minimal invasive surgical therapy for benign prostatic obstruction surgery: Perspectives from a global knowledge, attitude, and practice surveyBryan Kwun-Chung Cheng, Steffi Kar-Kei Yuen, Daniele Castellani, et al.World Journal of Urology|September 27, 2024
Young age and adequate BCG are key factors for optimal BCG treatment efficacy in non-muscle-invasive bladder cancerKang Liu, Rossella Nicoletti, Hongda Zhao, et al.BJU International|September 11, 2024
The potential benefits of concomitant statins treatment in patients with non-muscle-invasive bladder cancerKang Liu, Rossella Nicoletti, Hongda Zhao, et al.Pageof 6